PATENT CLAIM ANALYSIS

Application Number: 15756500
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["424", "078170"]

Abstract:
Disclosed is a hemostatic material, wherein a thrombin receptor activating agent is covalently coupled to a biocompatible matrix.

Claim (Index 7):
The method according to  claim 6 , wherein the thrombin receptor activating agent is a thrombin receptor activating peptide (TRAP), preferably TRAP8, TRAP7, TRAP6, TRAP1-41, SLIGKV (for PAR-2 (human)), TFRGAP (for PAR-3 (human)), GYPGQV (for PAR-4 (human)), or amidated forms thereof, as well as mixtures thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.17647
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14460353', '13173013', '14836014', '13758942', '10251703']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7359926003429118
- 35 USC 102 Novelty (BERT): 0.4927137156899393
- Combined Prediction Score: 0.7116647118776146
- Mean Citation Score: 216.677474
- Max Citation Score: 227.17107
- Similarity Product: 168.49715473311423

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test